Antonio Macciò
Antonio Macciò
Chief at Department of Gynecologic Oncology, A. Businco Hospital, Azienda Ospedaliera Brotzu, Cagliari
Verified email at aob.it
TitleCited byYear
Managing cancer-related anorexia/cachexia
G Mantovani, A Macciò, E Massa, C Madeddu
Drugs 61 (4), 499-514, 2001
2242001
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites
G Mantovani, A Macciò, L Mura, E Massa, MC Mudu, C Mulas, MR Lusso, ...
Journal of Molecular Medicine 78 (10), 554-561, 2000
2222000
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
G Mantovani, A Maccio, P Lai, E Massa, M Ghiani, MC Santona
Seminars in oncology 25 (2 Suppl 6), 45-52, 1998
2111998
Inflammation and ovarian cancer
A Macciò, C Madeddu
Cytokine 58 (2), 133-147, 2012
1922012
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy
G Gramignano, MR Lusso, C Madeddu, E Massa, R Serpe, L Deiana, ...
Nutrition 22 (2), 136-145, 2006
1782006
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia
G Mantovani, A Macciò, C Madeddu, R Serpe, E Massa, M Dessì, ...
The oncologist 15 (2), 200, 2010
1702010
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status
G Mantovani, A Macciò, C Madeddu, L Mura, G Gramignano, MR Lusso, ...
International Journal of Cancer 98 (1), 84-91, 2002
1642002
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment
G Mantovani, C Madeddu, A Macciò, G Gramignano, MR Lusso, E Massa, ...
Cancer Epidemiology and Prevention Biomarkers 13 (10), 1651-1659, 2004
1582004
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in …
G Mantovani, A Macciò, C Madeddu, G Gramignano, MR Lusso, R Serpe, ...
Cancer Epidemiology and Prevention Biomarkers 15 (5), 1030-1034, 2006
1512006
Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer …
G Mantovani, A Maccio, S Esu, P Lai, MC Santona, E Massa, D Dessi, ...
European Journal of Cancer 33 (4), 602-607, 1997
1381997
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of …
G Mantovani, A Macciò, C Madeddu, L Mura, G Gramignano, MR Lusso, ...
Journal of Molecular Medicine 81 (10), 664-673, 2003
1362003
Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms
G Mantovani, A Maccio, P Lai, E Massa, M Ghiani, MC Santona
Critical Reviews™ in Oncogenesis 9 (2), 1998
1211998
Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia
A Macciò, C Madeddu, D Massa, MC Mudu, MR Lusso, G Gramignano, ...
Blood 106 (1), 362-367, 2005
1172005
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at …
G Mantovani, A Macciò, C Madeddu, L Mura, G Gramignano, MR Lusso, ...
Free radical research 37 (2), 213-223, 2003
1152003
Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications
A Macciò, C Madeddu
The Scientific World Journal 11, 2020-2036, 2011
1132011
Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications
A Macciò, C Madeddu, G Gramignano, C Mulas, C Floris, D Massa, ...
Journal of molecular medicine 88 (7), 677-686, 2010
1112010
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
G Mantovani, A Macciò, C Madeddu, R Serpe, G Antoni, E Massa, ...
Journal of molecular medicine 88 (1), 85-92, 2010
1102010
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study
A Macciò, C Madeddu, G Gramignano, C Mulas, L Tanca, MC Cherchi, ...
haematologica 100 (1), 124-132, 2015
1032015
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results
G Mantovani, A Macciò, C Madeddu, G Gramignano, R Serpe, E Massa, ...
Nutrition 24 (4), 305-313, 2008
1032008
A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles …
A Macciò, C Madeddu, G Gramignano, C Mulas, C Floris, E Sanna, ...
Gynecologic oncology 124 (3), 417-425, 2012
1022012
The system can't perform the operation now. Try again later.
Articles 1–20